TMG releases report chronicling PACS usageTechnology Marketing Group has released a profile of PACS usage in the U.S. Based on the company's census survey data collected from PACS sites around the world, the PACS Benchmarking Report gathers
Technology Marketing Group has released a profile of PACS usage in the U.S. Based on the company's census survey data collected from PACS sites around the world, the PACS Benchmarking Report gathers information from more than 1700 sites, including hospitals with more than 200 beds and imaging centers that perform at least 10,000 procedures per year. Aimed at healthcare providers, the report analyzes average staff configurations, equipment, PACS usage, and annual equipment budgets. The PACS report is the first in a series Des Plaines, IL-based TMG expects to publish based on its census data.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.